HomeCompareGNTLF vs VICI

GNTLF vs VICI: Dividend Comparison 2026

GNTLF yields 200.00% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNTLF wins by $118.40M in total portfolio value
10 years
GNTLF
GNTLF
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full GNTLF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — GNTLF vs VICI

📍 GNTLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNTLFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNTLF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNTLF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNTLF
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, GNTLF beats the other by $50,633,412.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNTLF + VICI for your $10,000?

GNTLF: 50%VICI: 50%
100% VICI50/50100% GNTLF
Portfolio after 10yr
$60.17M
Annual income
$30,391,736.20/yr
Blended yield
50.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

GNTLF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
135.3
Piotroski
3/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNTLF buys
0
VICI buys
0
No recent congressional trades found for GNTLF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNTLFVICI
Forward yield200.00%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$119.36M$966.2K
Annual income after 10y$60,176,096.29$607,376.13
Total dividends collected$112.49M$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusSellBuy

Year-by-year: GNTLF vs VICI ($10,000, DRIP)

YearGNTLF PortfolioGNTLF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$30,700$20,000.00$11,361$941.49+$19.3KGNTLF
2$90,232$57,383.18$13,320$1,481.32+$76.9KGNTLF
3$254,173$157,624.56$16,284$2,405.01+$237.9KGNTLF
4$686,927$414,961.74$21,040$4,071.78+$665.9KGNTLF
5$1,783,118$1,048,106.39$29,209$7,285.49+$1.75MGNTLF
6$4,450,613$2,542,677.12$44,443$14,006.51+$4.41MGNTLF
7$10,693,420$5,931,263.38$75,822$29,512.55+$10.62MGNTLF
8$24,760,608$13,318,648.86$148,733$69,726.75+$24.61MGNTLF
9$55,315,649$28,821,798.66$344,394$189,413.75+$54.97MGNTLF
10$119,363,841$60,176,096.29$966,234$607,376.13+$118.40MGNTLF

GNTLF vs VICI: Complete Analysis 2026

GNTLFStock

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

Full GNTLF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this GNTLF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNTLF vs SCHDGNTLF vs JEPIGNTLF vs OGNTLF vs KOGNTLF vs MAINGNTLF vs NNNGNTLF vs EPRTGNTLF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.